Concepedia

Annie Liu

AL

Statistics

Publications

6

Citations

155

H-Index

6

Active since

2006

Affiliations

Janssen (United States)(Current)

Huntsman Cancer Institute

UCSF Helen Diller Family Comprehensive Cancer Center

University of Utah

University of California, San Francisco

Annie Liu is an author at Janssen (United States) specializing in molecular oncology, oncology, and medicine.

Publications per year

2006–2022

6

Publications

6

Sorting Nexin 1 Down-Regulation Promotes Colon Tumorigenesis

Lananh Nguyen, Matthew S. Holdren, Anthony P. Nguyen et al. · Clinical Cancer Research · 2006 · 38 citations · Full text

, , +15

ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells.

Xiaohua Gao, Yongbo Liu, Dorrah Deeb et al. · PubMed · 2013 · 37 citations · Full text

, , +16

Mutationally-activated PI3’-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase

J. Edward van Veen, Michael T. Scherzer, Julia Boshuizen et al. · eLife · 2019 · 24 citations · Full text

, , +17

Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis

Aria Vaishnavi, Joseph Juan, Maebh Jacob et al. · Cancer Research · 2022 · 24 citations · Full text

, , +17

Discovery of an Allosteric, Inactive Conformation-Selective Inhibitor of Full-Length HPK1 Utilizing a Kinase Cascade Assay

Weixue Wang, Laurence Mévellec, Annie Liu et al. · Biochemistry · 2021 · 19 citations

, , +11

1–5 of 6